Collaborative projects with industry
In the past years, we had three Innosuisse grants in collaboration with Swiss companies. The projects dealt with commercial applications of the sybody technology.
F. Hoffmann-La Roche AG
Project title: SwissBody-enabled
small molecule drug discovery
small molecule drug discovery
Duration: 2014-2017
Direct contact: Roger Dawson
LeadXpro AG
Project title: Swissbodies for
antibiotics drug discovery
antibiotics drug discovery
Duration: 2017-2020
Direct contact: Michael Hennig
Bühlmann Laboratories AG
Project title: Diagnose von Entzündungskrankheiten mittels neuartiger molekularer Binder
Duration: 2018-2021
Direct contact: Christian Gerhold